-
2 months ago | 
clinicalleader.com | Ross Jackson |Dan Schell |Jessica Cordes
How "Atomic Habits" Can Help Optimize Patient RecruitmentWith the third article in his series “Inspired Patient Recruitment — Taking Inspiration from Business Advice Bestsellers," Ross Jackson applies theories from "Atomic Habits" by James Clear to clinical trial patient recruitment.
-
Jan 7, 2025 | 
clinicalleader.com | Jessica Cordes
By Jessica Cordes, consultant, Clinical Excellence GmbH
Clinical research professionals have long understood the disparities in clinical research access and outcomes among diverse populations. In talking about those groups, various identifiers and terms have been used: unrepresented, underserved, and marginalized, to name a few. But when we use them, what do we mean exactly?
-
Dec 6, 2024 | 
clinicalleader.com | Jessica Cordes
Webinar: Personalized Medicine: Tailoring IRT/RTSM solutions to overcome challengesAdvanced IRT/RTSM can support precision medicine’s unique challenges, allowing you to meet its goal of matching the right treatments at the right dosages for each individual patient at the right time. Discover how it’s possible to tailor RTSM to meet specific precision medicine challenges of expiry, visit and personalized shipment management. Click here to learn more.
-
Nov 9, 2024 | 
clinicalleader.com | Dan Schell |Jessica Cordes |Matthew Jones |Julia Scanlon
OCTOBER'S BEST FEATURED EDITORIALGovernment Contract Advances Walgreens In Clinical SpaceWalgreen’s new $25 million deal with BARDA (Biomedical Advanced Research and Development Authority) is a huge win for the pharmacy chain. John Campbell, head of DCTs at Walgreens, explains the ins and outs of the study and what could be next for the company regarding its clinical trials division.
-
Nov 7, 2024 | 
clinicalleader.com | Jessica Cordes
By Jessica Cordes, principal, Clinical Trial Excellence GmbH
The World Medical Association (WMA) formulated the Declaration of Helsinki to outline ethical principles for conducting medical research involving human participants, including studies utilizing identifiable human material or data. This Declaration is designed to be read comprehensively, with each paragraph considered in the context of all other relevant sections.
-
Oct 25, 2024 | 
clinicalleader.com | Jessica Cordes |Dan Schell
With ICH M11 expected to be adopted by the end of the year, the next Clinical Leader Live digital event will host a panel discussion on the advantages of improving and simplifying the dataflow of clinical trials but also the challenges associated with creating a connected digital dataflow, including digital health channels, that spans from protocol to data collection to CSR. Register today and join us on 10/31 at 1 pm ET (10 am PT).
-
Oct 11, 2024 | 
clinicalleader.com | Jessica Cordes |Dan Schell |Pankaj Manon
Right-sized for biotech successIt’s not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We’ve got you. 3 Areas Needing Risk Management AttentionConsultant Jessica Cordes and medical affairs expert Oscar Segurado discuss the three key areas of risk in clinical trials- Enrollment, Patient Retention, and Adverse Events.
-
Oct 8, 2024 | 
clinicalleader.com | Jessica Cordes
Guest Column
| October 8, 2024
By Jessica Cordes, Clinical Excellence GmbH
Sponsor oversight and risk management play vital roles in maintaining data reliability, patient safety, and the effectiveness of clinical research. Effective sponsor oversight not only guarantees compliance with regulatory requirements but also enhances the overall quality of the clinical trial.
-
Oct 3, 2024 | 
clinicalleader.com | Dan Schell |Jessica Cordes
Webinar: From Crisis to Confidence in Medical WritingThe regulatory submission process is complex and filled with challenges that can jeopardize critical filings. In this session, we’ll explore the key obstacles medical writing submission specialists face today and share proven strategies to ensure successful submissions every time. Click here to learn more.
-
Sep 6, 2024 | 
clinicalleader.com | Jessica Cordes |Josh Buddle |Dan Schell
Webinar: Unleash the Power of IQVIA eCOA: A Deep DiveAs clinical trials increasingly rely on patient-focused outcomes data, it’s crucial to understand the latest features and best practices for eCOA platforms. In this session, IQVIA eCOA expert Edward Bartels will provide an overview of the eCOA landscape and how to effortlessly create a diary, schedule site/participant assessments, and manage translations and compliance.
